Total cash vs. overseas cash of select us biopharma companies Q3 2017

This statistic shows the total cash vs. overseas cash balances of select top U.S. pharmaceutical companies as of third quarter (Q3) in 2017 outside. In that period, the total cash of Amgen Inc. was 41 billion U.S. dollars of which 39 billion dollars were held outside the United States.

Total cash vs. overseas cash balances of select U.S. pharmaceutical companies as of Q3 2017

Exclusive Premium statistic

You need a Single Account for unlimited access.

  • Full access to 1m statistics

  • Incl. source references

  • Available to download in PNG, PDF, XLS format

Single Account

$39 $59 per month *
in the first 12 months
33% Discount until September 30th
*Duration: 12 months, billed annually, single license

Access to this and all other statistics on 80,000 topics from

$468 / Year
$708 / Year

Show detailed source information?
Register for free
Already a member?
Log in
Sources

Release date

December 2017

Region

Worldwide

Survey time period

Q3 2017

Supplementary notes

* These companies have said that nearly all of their cash is overseas.
** The company has said that 80 to 90% of its cash is overseas.

Statista Accounts: Access All Statistics. Starting from $468 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account.

Single Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$59 $39 / Month *
in the first 12 months
Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract; Prices do not include sales tax.

Statistics on "Biogen"

Statista Accounts: Access All Statistics. Starting from $468 / Year
Learn more about how Statista can support your business.